Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Eukaryotic Gene Expression
Factor de Impacto: 1.841 Factor de Impacto de 5 años: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v22.i4.50
pages 309-324

Integrin Control of Tumor Invasion

Dara S. Missan
Center for Cell Biology & Cancer Research, Albany Medical College, Albany, New York, USA
Michael DiPersio
Center for Cell Biology & Cancer Research, Albany Medical College, Albany, New York, USA


Metastasis is the leading cause of death in cancer patients, and strategies to inhibit tumor cell invasion are a major focus of current efforts to develop cancer treatments. The extracellular matrix (ECM) provides both structural support and extracellular cues that regulate invasive tumor growth, and tumor-associated changes in ECM contribute to cancer progression. Integrins, the major receptors for cell adhesion to ECM, are important at every stage of cancer and occupy a critical position as transducers of chemical and mechanical signals that control tumor cell responses to ECM (i.e., outside-in signaling), as well as tumor-mediated changes to ECM that facilitate invasive growth and metastasis (i.e., inside-out signaling). Integrins are therefore attractive therapeutic targets for antagonistic agents. Here, we provide an overview of cancer-promoting functions of integrins on tumor cells, with a focus on roles in regulating cell invasion, ECM remodeling, tumor angiogenesis, and gene expression. We will also discuss how integrin functions are modulated by ECM ligands outside the cell, cytoskeletal/signaling proteins inside the cell, and other cell surface proteins. Finally, we will discuss current progress towards developing integrin antagonists for clinical use, including barriers that must still be overcome before integrins can be fully exploited as therapeutic targets.

Articles with similar content:

Role of the Cytoskeletal Protein Paxillin in Oncogenesis
Critical Reviews™ in Oncogenesis, Vol.11, 2000, issue 1
Paul T. Morrison, Ravi Salgia, Martin Sattler, Evan Pisick
Therapeutic Intervention with Breast Cancer Metastasis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.12, 2002, issue 2
Dina Chelouche Lev, Janet E. Price
Nitrosothiol Signaling in Anoikis Resistance and Cancer Metastasis
Forum on Immunopathological Diseases and Therapeutics, Vol.3, 2012, issue 2
Neelam Azad, Anand Krishnan V. Iyer, Liying Wang, Sudjit Luanpitpong, Yon Rojanasakul
Anoikis and EMT: Lethal "Liaisons" during Cancer Progression
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Natasha Kyprianou, Zheng Cao, Theodore Livas
Targeting Integrins in Cancer
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 3-4
Chiara Pazzagli, Sandra Donnini